REGULATION OF PROLACTIN SECRETION AT THE LACTOTROPH
泌乳素泌乳素分泌的调节
基本信息
- 批准号:2701092
- 负责人:
- 金额:$ 21.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-05-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:G protein antisense nucleic acid arachidonate biological signal transduction calcium calcium channel dopamine dopamine receptor eicosanoid metabolism electrophysiology fluorescence microscopy hormone regulation /control mechanism hypothalamic pituitary axis laboratory rat neurohormones phospholipase A2 pituitary gland prolactin prolactin releasing /inhibiting factor receptor coupling secretion tissue /cell culture voltage /patch clamp
项目摘要
Prolactin (pRL) is a hormone which originates in cells of the anterior
pituitary gland, lactotrophs, and plays multiple physiological roles in
all mammals. Not only does it promote lactation in all mammals, but it
also plays a role in maternal behavior, maintenance of pregnancy as well
as osmoregulation and the immune response. Dopamine (DA) is a well
established physiological inhibitor of PRL secretion. It originates in
cells, neurons, within a specialized area of the brain, the hypothalamus,
which sends projections that terminate upon the vasculature connecting the
hypothalamus with the pituitary gland. It has recently been shown that DA
is also a physiological stimulator of PRL secretion. The long term
objective of this application is to characterize the mechanism whereby DA
has opposing physiological effects on PRL secretion. Using measurements of
PRL secretion as well as intracellular transduction events, the Specific
Aims of this project will be to: (1) determine which DA receptors on the
lactotroph are responsible for stimulation of PRL secretion, (2) determine
which G-proteins are linked to stimulation versus inhibition of PRL
secretion by DA, (3) determine if the intracellular lipids are involved in
the stimulation of PRL secretion by DA and (4) determine the role of
calcium in DA-stimulated PRL secretion. Since PRL has so many multi-
faceted roles in the physiology of the organism, it is critical for
purposes of possible therapeutic approaches to diseases involving PRL that
all aspects of its physiological control be clarified. For example, both
benign and malignant diseases of the mammary gland are approached by
manipulating pituitary PRL secretion. Thorough knowledge of the control of
PRL secretion will allow other approaches to its manipulation in disease
states.
催乳素(PRL)是一种激素,起源于前室的细胞
垂体,乳酸营养,并在
所有哺乳动物。它不仅促进了所有哺乳动物的泌乳,而且还可以
还在孕产妇行为中发挥作用,维持怀孕
作为渗透调节和免疫反应。多巴胺(DA)是一口井
建立的PRL分泌的生理抑制剂。它起源于
细胞,神经元,在大脑的专业区域内,下丘脑,
发送的投影终止于连接的脉管系统
下丘脑与垂体。最近已经证明了DA
也是PRL分泌的生理刺激剂。长期
该应用的目的是表征DA的机制
对PRL分泌具有相反的生理影响。使用的测量
PRL分泌以及细胞内转导事件,特定
该项目的目的是:(1)确定哪些DA受体
乳营养素负责刺激PRL分泌,(2)确定
哪种G蛋白与PRL的刺激与抑制有关
DA的分泌,(3)确定细胞内脂质是否参与
DA和(4)对PRL分泌的刺激确定
DA刺激的PRL分泌中的钙。由于PRL有很多多
在生物体的生理学中角色,对
涉及PRL的疾病的可能治疗方法的目的
澄清其生理控制的所有方面。例如,两者
乳腺的良性和恶性疾病已通过
操纵垂体PRL分泌。对控制的彻底了解
PRL分泌将允许其他方法来操纵疾病
国家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC Edward FREEMAN其他文献
MARC Edward FREEMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC Edward FREEMAN', 18)}}的其他基金
Regulation of prolactin secretion at the lactotroph
泌乳素细胞催乳素分泌的调节
- 批准号:
7990212 - 财政年份:2009
- 资助金额:
$ 21.74万 - 项目类别:
SECRETION OF PROLACTIN--REGULATION BY ENDOTHELIN
催乳素的分泌——内皮素的调节
- 批准号:
6627410 - 财政年份:2000
- 资助金额:
$ 21.74万 - 项目类别:
SECRETION OF PROLACTIN--REGULATION BY ENDOTHELIN
催乳素的分泌——内皮素的调节
- 批准号:
6343255 - 财政年份:2000
- 资助金额:
$ 21.74万 - 项目类别:
SECRETION OF PROLACTIN--REGULATION BY ENDOTHELIN
催乳素的分泌——内皮素的调节
- 批准号:
6684183 - 财政年份:2000
- 资助金额:
$ 21.74万 - 项目类别:
SECRETION OF PROLACTIN--REGULATION BY ENDOTHELIN
催乳素的分泌——内皮素的调节
- 批准号:
6043640 - 财政年份:2000
- 资助金额:
$ 21.74万 - 项目类别:
SECRETION OF PROLACTIN--REGULATION BY ENDOTHELIN
催乳素的分泌——内皮素的调节
- 批准号:
6490472 - 财政年份:2000
- 资助金额:
$ 21.74万 - 项目类别:
REGULATION OF PROLACTIN SECRETION AT THE LACTOTROPH
泌乳素泌乳素分泌的调节
- 批准号:
2790855 - 财政年份:1998
- 资助金额:
$ 21.74万 - 项目类别:
REGULATION OF PROLACTIN SECRETION AT THE LACTOTROPH
泌乳素泌乳素分泌的调节
- 批准号:
2142842 - 财政年份:1996
- 资助金额:
$ 21.74万 - 项目类别:
REGULATION OF PROLACTIN SECRETION AT THE LACTOTROPH
泌乳素泌乳素分泌的调节
- 批准号:
658593 - 财政年份:1995
- 资助金额:
$ 21.74万 - 项目类别:
Regulation of prolactin secretion at the lactotroph
泌乳素细胞催乳素分泌的调节
- 批准号:
7017086 - 财政年份:1992
- 资助金额:
$ 21.74万 - 项目类别:
相似国自然基金
反义寡核苷酸—核酸适配体嵌合体的靶向分子设计与催化降解机理研究
- 批准号:22307124
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
维生素E-PEG修饰自组装反义核酸药物靶向MAPK14和BChE治疗神经炎症诱发阿尔兹海默症的应用基础研究
- 批准号:22207006
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
维生素E-PEG修饰自组装反义核酸药物靶向MAPK14和BChE治疗神经炎症诱发阿尔兹海默症的应用基础研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
持续碱基配对竞争降低反义锁核酸药物脱靶毒性的研究
- 批准号:52203187
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
持续碱基配对竞争降低反义锁核酸药物脱靶毒性的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
REGULATION OF PROLACTIN SECRETION AT THE LACTOTROPH
泌乳素泌乳素分泌的调节
- 批准号:
2790855 - 财政年份:1998
- 资助金额:
$ 21.74万 - 项目类别:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
新型二十烷酸阿南达胺的生物合成
- 批准号:
2122673 - 财政年份:1995
- 资助金额:
$ 21.74万 - 项目类别:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
新型二十烷酸阿南达胺的生物合成
- 批准号:
2443494 - 财政年份:1995
- 资助金额:
$ 21.74万 - 项目类别:
REGULATION OF PROLACTIN SECRETION AT THE LACTOTROPH
泌乳素泌乳素分泌的调节
- 批准号:
6131315 - 财政年份:1992
- 资助金额:
$ 21.74万 - 项目类别:
REGULATION OF PROLACTIN SECRETION AT THE LACTOTROPH
泌乳素泌乳素分泌的调节
- 批准号:
2414807 - 财政年份:1992
- 资助金额:
$ 21.74万 - 项目类别: